Bank of America’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-548,367
| Closed | -$2.48M | – | 5990 |
|
|
2025
Q4 | $2.48M | Buy |
548,367
+105,043
| +24% | +$538K | ﹤0.01% | 3899 |
|
|
2025
Q3 | $2.39M | Buy |
443,324
+347,854
| +364% | +$1.88M | ﹤0.01% | 4668 |
|
|
2025
Q2 | $518K | Buy |
95,470
+87,211
| +1,056% | +$346K | ﹤0.01% | 5686 |
|
|
2025
Q1 | $22.9K | Buy |
8,259
+3,168
| +62% | +$11K | ﹤0.01% | 6940 |
|
|
2024
Q4 | $17.4K | Sell |
5,091
-7,723
| -60% | -$22.3K | ﹤0.01% | 6873 |
|
|
2024
Q3 | $37.7K | Buy |
12,814
+3,012
| +31% | +$9.92K | ﹤0.01% | 6623 |
|
|
2024
Q2 | $33.3K | Sell |
9,802
-12,137
| -55% | -$39.7K | ﹤0.01% | 6619 |
|
|
2024
Q1 | $66.5K | Buy |
21,939
+2,868
| +15% | +$10.1K | ﹤0.01% | 6420 |
|
|
2023
Q4 | $80.3K | Buy |
19,071
+7,434
| +64% | +$40.3K | ﹤0.01% | 6463 |
|
|
2023
Q3 | $79.5K | Sell |
11,637
-2,500
| -18% | -$22.1K | ﹤0.01% | 6342 |
|
|
2023
Q2 | $147K | Sell |
14,137
-142,267
| -91% | -$1.27M | ﹤0.01% | 6029 |
|
|
2023
Q1 | $1.09M | Buy |
156,404
+96,917
| +163% | +$845K | ﹤0.01% | 4835 |
|
|
2022
Q4 | $359K | Buy |
59,487
+48,164
| +425% | +$356K | ﹤0.01% | 5601 |
|
|
2022
Q3 | $89K | Sell |
11,323
-49,051
| -81% | -$572K | ﹤0.01% | 6396 |
|
|
2022
Q2 | $822K | Buy |
60,374
+30,705
| +103% | +$508K | ﹤0.01% | 5072 |
|
|
2022
Q1 | $582K | Sell |
29,669
-43,216
| -59% | -$863K | ﹤0.01% | 5727 |
|
|
2021
Q4 | $2.5M | Buy |
72,885
+51,856
| +247% | +$2.09M | ﹤0.01% | 4335 |
|
|
2021
Q3 | $1.15M | Sell |
21,029
-9,610
| -31% | -$579K | ﹤0.01% | 4933 |
|
|
2021
Q2 | $2.25M | Buy |
30,639
+14,804
| +93% | +$1.48M | ﹤0.01% | 4221 |
|
|
2021
Q1 | $1.45M | Sell |
15,835
-11,196
| -41% | -$1.09M | ﹤0.01% | 4516 |
|
|
2020
Q4 | $2.19M | Buy |
27,031
+13,147
| +95% | +$1.01M | ﹤0.01% | 3874 |
|
|
2020
Q3 | $646K | Buy |
+13,884
| New | +$775K | ﹤0.01% | 4525 |
|
Bank of America's CVAC Position: Q1 2026 in Review
Bank of America sold out of CureVac (CVAC) in Q1 2026, closing a stake of 548,367 shares — an estimated $2.48M sold.
Bank of America first reported a position in CVAC in Q3 2020 and held it in 22 quarters. The position peaked at $2.5M in Q4 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Bank of America reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 548,367 CureVac shares in Q1 2026, an estimated $2.48M.
- Bank of America first reported a position in CureVac in Q3 2020 and held it in 22 quarters.
- Bank of America's CureVac position peaked at $2.5M in Q4 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.